Public procurement notice: Contract Notice
Published: 2020-03-18
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33660000
Estimated value: 14040297 GBP
Submission deadline: 2020-04-21
Award criteria: The most economic tender

Technical requirements: This framework agreement is for the supply of ENT, ophthalmology and skin medicines/medical devices to health boards across NHS Scotland.
The goods have been split into two (2) categories, each of which is identified as a ‘Lot’. Full details of each Lot is contained in section II.2) of this notice.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978 and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Supply of All ENT, ophthalmology and skin medicines/medical devices to NHS Scotland in a range of presentations. The authority intends awarding a single supplier framework agreement on a line by line basis. Full details can be found within the ITT.
This framework includes the option to extend for up to a total period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978 and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Supply of artificial saliva products, eye preparations and skin creams in a range of presentations to NHS Scotland. The authority intends awarding each product line as a multi supplier unranked framework agreement on a line by line basis to an envisaged maximum of six (6) framework participants. Full details can be found within the ITT.
This framework includes the option to extend for up to a total period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) potential framework participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered medicines at the date of framework start date;
(b) potential framework participants and any subcontractor(s) must possess valid certification of BS EN ISO 9001 or equivalent;
(c) all tendered goods must comply with the MHRA best practice guidance on labelling and packaging and the National Patient Safety Agency (‘NPSA’) guidelines on packaging and labelling on pack design;
(d) potential framework participants must be able to demonstrate that all consumables/ancillaries and equipment supplied under this framework are CE marked, at the date of the tender submission.
(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered medicines at the date of submission of the tender should be included in the qualification envelope of the ITT under the technical and professional ability: quality control.
(b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the qualification envelope of the ITT under technical and professional ability: quality assurance schemes.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 14040297